← Back to Search

Prolonged Exposure Therapy for PTSD After Spinal Cord Injury

N/A

Recruiting

Led By Mark B Powers, PhD

Research Sponsored by Baylor Research Institute

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

18 years of age or older

Admitted to the inpatient rehabilitation hospital diagnosed with a SCI following a traumatic event

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline, 1 month, 3 months ,6 months

Summary

This trial will compare the effects of a common therapy for PTSD against a more intensive exposure-based therapy for people with spinal cord injuries receiving inpatient rehabilitation.

Who is the study for?

This trial is for adults over 18 who have experienced a traumatic spinal cord injury and are currently in an inpatient rehabilitation hospital. It's designed to help those struggling with posttraumatic stress as a result of their injury.

What is being tested?

The study is testing Brief Prolonged Exposure (Brief PE) therapy against the standard treatment typically given for posttraumatic stress in patients with spinal cord injuries during their rehab stay.

What are the potential side effects?

While not explicitly stated, side effects may include temporary increases in distress due to recalling traumatic events, which is common with exposure therapies.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 18 years old or older.

Select...

I am in rehab for a spinal cord injury from an accident.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline, 1 month, 3 months ,6 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline, 1 month, 3 months ,6 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 1 month, 3 months ,6 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Change in PSSI-5: PTSD Symptom Scale - Interview for DSM-5

Secondary study objectives

Change in Generalized Anxiety Disorder-7 Item

Change in Patient Health Questionnaire-9

Trial Design

2Treatment groups

Experimental Treatment

Placebo Group

Group I: Brief Prolonged ExposureExperimental Treatment1 Intervention

Experimental: Brief Prolonged Exposure Participants will receive Brief PE. Subjects in the Brief Prolonged Exposure (BPE) intervention group will additionally receive 3 total therapy sessions, each lasting about 60 minutes spaced about 1-7 days apart. Sessions include education about common reactions to trauma, breathing retraining, identification of self-care tasks and prolonged (repeated) imaginal exposure to trauma memories. Any missed sessions will be made up by scheduling multiple sessions in subsequent weeks. Individuals in the BPE group will complete a screener and then survey questionnaires/ interviews at 1, 3, and 6 months from Baseline.

Group II: Treatment as UsualPlacebo Group1 Intervention

Participants in the Treatment as Usual (TAU) group will not receive Prolonged Exposure therapy, but will instead receive the standard clinical treatment received by all persons with spinal cord injury (SCI) at the rehabilitation facility. TAU participants will complete questionnaires/interviews at 1, 3, and 6 months from Baseline.

0 / 2Eligibility criteria met